Key Segments:
By Offering
-
Bioreactors & Fermenters
-
Chromatography Systems & Consumables
-
Filtration Systems & Single-Use Assemblies
-
Cell Culture Media, Buffers & Reagents
-
Process Analytical Technology & Automation Software
-
Other Offerings
By Process
-
Upstream Processing
-
Downstream Processing
By Application
-
Monoclonal Antibodies
-
Vaccines
-
Cell and Gene Therapy
-
Recombinant Proteins
-
Other Applications
By End User
-
Biopharmaceutical and Biotechnology Companies
-
Contract Manufacturing and Research Organizations
-
Academic and Research Institutes
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Sartorius, Thermo Fisher Scientific, Repligen Corporation, Merck KGaA (MilliporeSigma), Danaher Corporation (Cytiva, Pall), Getinge, Eppendorf, Corning, Entegris, FUJIFILM Biotechnologies, Avantor, ABEC, Asahi Kasei Bioprocess, Univercells Technologies, and GEA Group, among others.
Key opportunities include expanding cell and gene therapy manufacturing pipelines, growing adoption of modular single-use facility designs, and rising contract manufacturing investment in continuous and intensified processing platforms.
The market is driven by biomanufacturers' sustained shift toward perfusion-based upstream platforms and continuous downstream purification, which reduce facility footprint and cost of goods relative to traditional batch processing.
The Bioreactors & Fermenters segment dominated the Continuous Bioprocessing Market, accounting for approximately 29.45% share in 2025.
The North America region dominated the Continuous Bioprocessing Market in 2025 with approximately 38.50% revenue share.
